Literature DB >> 31552471

Metabolic reprogramming in osteoclasts.

Kyung-Hyun Park-Min1,2,3.   

Abstract

Osteoclasts are bone-resorbing cells that play an essential role in the remodeling of the bone. Defects in osteoclasts thus result in unbalanced bone remodeling, leading to numerous pathological conditions such as osteoporosis, bone metastasis, and inflammatory bone erosion. Metabolism is any process a cell utilizes to meet its energetic demand for biological functions. Along with signaling pathways and osteoclast-specific gene expression programs, osteoclast differentiation activates metabolic programs. The energy generated from metabolic reprogramming in osteoclasts not only supports the phenotypic changes from mononuclear precursor cells to multinuclear osteoclasts, but also facilitates bone resorption, a major function of terminally differentiated, mature osteoclasts. While oxidative phosphorylation is studied as a major metabolic pathway that fulfills the energy demands of osteoclasts, all metabolic pathways are closely interconnected. Therefore, it remains important to understand the various aspects of osteoclast metabolism, including the roles and effects of glycolysis, glutaminolysis, fatty acid synthesis, and fatty acid oxidation. Targeting the pathways associated with metabolic reprogramming has shown beneficial effects on pathological conditions. As a result, it is clear that a deeper understanding of metabolic regulation in osteoclasts will offer broader translational potential for the treatment of human bone disorders.

Entities:  

Keywords:  Metabolic reprogramming; Metabolism; Osteoclasts

Mesh:

Substances:

Year:  2019        PMID: 31552471     DOI: 10.1007/s00281-019-00757-0

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  60 in total

Review 1.  HIF transcription factors, inflammation, and immunity.

Authors:  Asis Palazon; Ananda W Goldrath; Victor Nizet; Randall S Johnson
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

Review 2.  The role of osteoclast differentiation and function in skeletal homeostasis.

Authors:  Kyoji Ikeda; Sunao Takeshita
Journal:  J Biochem       Date:  2015-11-03       Impact factor: 3.387

Review 3.  The multifaceted contributions of mitochondria to cellular metabolism.

Authors:  Jessica B Spinelli; Marcia C Haigis
Journal:  Nat Cell Biol       Date:  2018-06-27       Impact factor: 28.824

Review 4.  PPARγ in bone homeostasis.

Authors:  Yihong Wan
Journal:  Trends Endocrinol Metab       Date:  2010-09-20       Impact factor: 12.015

5.  Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4.

Authors:  Helen J Knowles; Anne-Marie Cleton-Jansen; Eberhard Korsching; Nicholas A Athanasou
Journal:  FASEB J       Date:  2010-07-28       Impact factor: 5.191

6.  Ligand Activation of ERRα by Cholesterol Mediates Statin and Bisphosphonate Effects.

Authors:  Wei Wei; Adam G Schwaid; Xueqian Wang; Xunde Wang; Shili Chen; Qian Chu; Alan Saghatelian; Yihong Wan
Journal:  Cell Metab       Date:  2016-01-14       Impact factor: 27.287

7.  Intracellular and extracellular ATP coordinately regulate the inverse correlation between osteoclast survival and bone resorption.

Authors:  Tsuyoshi Miyazaki; Mitsuyasu Iwasawa; Tomoki Nakashima; Shuuichi Mori; Kazuhiro Shigemoto; Hiroaki Nakamura; Hideki Katagiri; Hiroshi Takayanagi; Sakae Tanaka
Journal:  J Biol Chem       Date:  2012-09-17       Impact factor: 5.157

8.  THE FINE STRUCTURE OF BONE CELLS.

Authors:  H R Dudley; D Spiro
Journal:  J Biophys Biochem Cytol       Date:  1961-12-01

9.  Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss.

Authors:  Sébastien Lucas; Yasunori Omata; Jörg Hofmann; Martin Böttcher; Aida Iljazovic; Kerstin Sarter; Olivia Albrecht; Oscar Schulz; Brenda Krishnacoumar; Gerhard Krönke; Martin Herrmann; Dimitrios Mougiakakos; Till Strowig; Georg Schett; Mario M Zaiss
Journal:  Nat Commun       Date:  2018-01-04       Impact factor: 14.919

10.  Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt.

Authors:  Kerstin Tiedemann; Damien Le Nihouannen; Jenna E Fong; Osama Hussein; Jake E Barralet; Svetlana V Komarova
Journal:  Front Cell Dev Biol       Date:  2017-05-18
View more
  17 in total

1.  Role of Lysine-Specific Demethylase 1 in Metabolically Integrating Osteoclast Differentiation and Inflammatory Bone Resorption Through Hypoxia-Inducible Factor 1α and E2F1.

Authors:  Kohei Doi; Koichi Murata; Shuji Ito; Akari Suzuki; Chikashi Terao; Shinichiro Ishie; Akio Umemoto; Yoshiki Murotani; Kohei Nishitani; Hiroyuki Yoshitomi; Takayuki Fujii; Ryu Watanabe; Motomu Hashimoto; Kosaku Murakami; Masao Tanaka; Hiromu Ito; Kyung-Hyun Park-Min; Lionel B Ivashkiv; Akio Morinobu; Shuichi Matsuda
Journal:  Arthritis Rheumatol       Date:  2022-04-27       Impact factor: 15.483

2.  Osteoimmunology: entwined regulation of integrated systems.

Authors:  Mary C Nakamura
Journal:  Semin Immunopathol       Date:  2019-09       Impact factor: 9.623

3.  Interleukin-34 Reprograms Glycolytic and Osteoclastic Rheumatoid Arthritis Macrophages via Syndecan 1 and Macrophage Colony-Stimulating Factor Receptor.

Authors:  Katrien Van Raemdonck; Sadiq Umar; Karol Palasiewicz; Michael V Volin; Hatem A Elshabrawy; Bianca Romay; Chandana Tetali; Azam Ahmed; M Asif Amin; Ryan K Zomorrodi; Nadera Sweiss; Shiva Shahrara
Journal:  Arthritis Rheumatol       Date:  2021-09-22       Impact factor: 10.995

Review 4.  Regulation of Osteoclast Differentiation and Activity by Lipid Metabolism.

Authors:  Haemin Kim; Brian Oh; Kyung-Hyun Park-Min
Journal:  Cells       Date:  2021-01-07       Impact factor: 6.600

5.  Diabetes Medication Metformin Inhibits Osteoclast Formation and Activity in In Vitro Models for Periodontitis.

Authors:  Lucy Y Tao; Katarzyna B Łagosz-Ćwik; Jolanda M A Hogervorst; Ton Schoenmaker; Aleksander M Grabiec; Tim Forouzanfar; Fridus A van der Weijden; Teun J de Vries
Journal:  Front Cell Dev Biol       Date:  2022-01-13

6.  Statin Therapy and the Risk of Osteoporotic Fractures in Patients with Metabolic Syndrome: a Nested Case-Control Study.

Authors:  Kyoung Jin Kim; Jimi Choi; Ji Yoon Kim; Jae Hyun Bae; Kyeong Jin Kim; Hee Young Kim; Hye Jin Yoo; Ji A Seo; Nan Hee Kim; Kyung Mook Choi; Sei Hyun Baik; Sin Gon Kim; Nam Hoon Kim
Journal:  J Lipid Atheroscler       Date:  2021-07-06

7.  The Role and Mechanism of Exosomes from Umbilical Cord Mesenchymal Stem Cells in Inducing Osteogenesis and Preventing Osteoporosis.

Authors:  Ge Yahao; Wang Xinjia
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

8.  Gut microbiota modulates osteoclast glutathione synthesis and mitochondrial biogenesis in mice subjected to ovariectomy.

Authors:  Yin Yuan; Jing Yang; Aoxiang Zhuge; Lanjuan Li; Shuo Ni
Journal:  Cell Prolif       Date:  2022-01-26       Impact factor: 6.831

Review 9.  The Role of Osteoclast Energy Metabolism in the Occurrence and Development of Osteoporosis.

Authors:  Wacili Da; Lin Tao; Yue Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-12       Impact factor: 5.555

Review 10.  The M-CSF receptor in osteoclasts and beyond.

Authors:  Se Hwan Mun; Peter Sang Uk Park; Kyung-Hyun Park-Min
Journal:  Exp Mol Med       Date:  2020-08-17       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.